{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:20:54Z","timestamp":1780708854483,"version":"3.54.1"},"reference-count":48,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background: Chronic inflammation and the development of cancer are closely linked, with components that comprise the tumour microenvironment\u2014including proinflammatory cytokines\u2014exerting essential tumourigenic effects. These proinflammatory cytokines include IL-1\u03b2, which has been reported to be overexpressed in several cancers and shown to activate several signalling pathways. These pathways may involve kinases such as AKT (serine\/threonine kinase) and Src (Proto-oncogene tyrosine-protein kinase), and have a broad capacity to activate nuclear factors, including NF-\u03baB (Nuclear Factor kappa-light-chain-enhancer of activated B cells), which can regulate the transcription of genes encoding proteins such as cIAP1 (Cellular Inhibitor of Apoptosis Protein 1), Bcl-2 (B-cell lymphoma 2), and cyclin D1, thereby regulating processes like apoptosis and cell cycle inhibition. Objectives: The aim of this study was to investigate the role of IL-1\u03b2 (Interleukin-1 beta) in regulating cell death and proliferation in RS4:11 leukaemic lymphoblasts via the PI3K (Phosphoinositide 3-kinase)\/AKT\/Src\/NF-\u03baB pathway using an in vitro experimental approach. Methods: We employed flow cytometry to determine the expression levels and phosphorylation status of various proteins; proliferation was assessed using the CCK-8 kit, and apoptosis was evaluated with the Annexin V kit. Results: Our findings indicate that the IL-1\u03b2-activated signalling pathway modulates these cellular processes in leukaemic lymphoblasts. Conclusions: We therefore conclude that IL-1\u03b2 exerts significant effects on cell death and proliferation in leukaemic lymphoblasts through the PI3K\/AKT\/NF-\u03baB pathway, with the study\u2019s findings indicating that an inflammatory environment may promote such lymphoblasts to acquire neoplastic characteristics. As such, the proteins involved in the effects evaluated in this work could be considered as potential therapeutic targets for the treatment of Acute Lymphoblastic Leukaemia (ALL).<\/jats:p>","DOI":"10.3390\/biomedicines14010041","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T11:22:14Z","timestamp":1766575334000},"page":"41","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["IL-1\u03b2 Controls Proliferation, Apoptosis, and Necroptosis Through the PI3K\/AKT\/Src\/NF-\u03baB Pathway in Leukaemic Lymphoblasts"],"prefix":"10.3390","volume":"14","author":[{"given":"Zitlal-Lin","family":"Victoria-Avila","sequence":"first","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-6484","authenticated-orcid":false,"given":"Elba","family":"Reyes-Maldonado","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-1215","authenticated-orcid":false,"given":"Mar\u00eda Lilia","family":"Dom\u00ednguez-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8070-0415","authenticated-orcid":false,"given":"Jorge","family":"Vela-Ojeda","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aranza","family":"Lozada-Ruiz","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5464-6171","authenticated-orcid":false,"given":"Omar Rafael","family":"Alem\u00e1n","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"},{"name":"Departamento de Inmunolog\u00eda, Instituto de Investigaciones Biom\u00e9dicas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Mexico City 04510, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ang\u00e9lica","family":"Lezama","sequence":"additional","affiliation":[{"name":"Escuela Nacional de Ciencias Biol\u00f3gicas, Instituto Polit\u00e9cnico Nacional Prolongaci\u00f3n de Carpio y Plan de Ayala, Col. Santo Tomas, Mexico City 11340, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.cdd.4401874","article-title":"Targeting NF-kB in hematologic malignancies","volume":"13","author":"Braun","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/aam.aam_56_18","article-title":"Inflammation and cancer","volume":"18","author":"Singh","year":"2019","journal-title":"Ann. Afr. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12943-025-02243-8","article-title":"Inflammation in cancer: Therapeutic opportunities from new insights","volume":"24","author":"Xie","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2024.11.011","article-title":"Cytokines in cancer","volume":"43","author":"Kureshi","year":"2025","journal-title":"Cancer Cell"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bent, R., Moll, L., Grabbe, S., and Bros, M. (2018). Interleukin-1 Beta\u2014A Friend or Foe in Malignancies. Int. J. Mol. Sci., 8.","DOI":"10.3390\/ijms19082155"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.canlet.2013.05.033","article-title":"Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance","volume":"337","author":"Diakowska","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12288-014-0339-7","article-title":"Assessment of interleukin 1\u03b2 serum level in different responder groups stages of chronic myeloid leukemia patients on imatinb mesylate therapy","volume":"30","author":"Matti","year":"2014","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/wsbm.1331","article-title":"Signaling via the NF\u03baB system","volume":"8","author":"Mitchell","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"ref_9","first-page":"40","article-title":"Acute lymphoblastic leukemia","volume":"32","author":"Chan","year":"2002","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1128\/MCB.19.7.4798","article-title":"Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65\/RelA subunit","volume":"19","author":"Sizemore","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"key":"ref_12","unstructured":"(2025, October 30). American Type Culture Collection, R.S.4.; 11 Cell Line (CRL-1873) Manassas, VA, USA. Available online: https:\/\/www.atcc.org\/products\/crl-1873."},{"key":"ref_13","unstructured":"(2025, October 30). RS4:11 Cells. Available online: https:\/\/www.cytion.com\/es\/RS4-11-Celulas\/305360."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-5793(95)00153-Z","article-title":"Wortmannin, a specific inhibitor of phosphatidylinositol-3 kinase, blocks osteoclastic bone resorption","volume":"361","author":"Nakamura","year":"1995","journal-title":"FEBS Lett."},{"key":"ref_15","first-page":"5059","article-title":"Src kinase inhibitor PP2 regulates the biological characteristics of A549 cells via the PI3K\/AKT signaling pathway","volume":"16","author":"Dai","year":"2018","journal-title":"Oncol Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41419-019-2157-1","article-title":"NEK7 interacts with NLRP3 to modulate the pyroptosis in inflammatory bowel disease via NF-\u03baB signaling","volume":"10","author":"Chen","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.19.9.5923","article-title":"NF-kappaB induces expression of the Bcl-2 homologue A1\/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis","volume":"19","author":"Wang","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"ref_18","first-page":"969","article-title":"The SMACmimetic AT-101 exhibits anti-tumor in lung adenocarcinoma cells by the IAPs\/caspase-dependent apoptosis p65-NF\u0199Bcross-talk","volume":"24","author":"Ahmad","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11427-021-2140-8","article-title":"Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4\/6 inhibitor in breast cancer that can be reversed by PI3K\/mTOR inhibitors","volume":"66","author":"Cai","year":"2023","journal-title":"Sci. China Life Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/sj.leu.2403457","article-title":"Interleukin-1beta maintains an apoptosis-resistant phenotype in the blast cells of acute myeloid leukaemia via multiple pathways","volume":"18","author":"Turzanski","year":"2004","journal-title":"Leukemia"},{"key":"ref_22","first-page":"2971","article-title":"Autocrine interleukin-1beta production in leukemia: Evidence for the involvement of mutated RAS","volume":"15","author":"Beaupre","year":"1999","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"29167","DOI":"10.1074\/jbc.272.46.29167","article-title":"Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation","volume":"272","author":"Reddy","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/ijc.22599","article-title":"IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src\/RhoA\/ROCK signaling pathway","volume":"120","author":"Lin","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Diep, S., Maddukuri, M., Yamauchi, S., Geshow, G., and Delk, N.A. (2022). Interleukin-1 and Nuclear Factor Kappa B Signaling Promote Breast Cancer Progression and Treatment Resistance. Cells, 11.","DOI":"10.3390\/cells11101673"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/abbs\/gmr050","article-title":"Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K\/AKT and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells","volume":"43","author":"Zhang","year":"2011","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ghoneum, A., and Said, N. (2019). PI3K-AKT -mTOR and NF\u03baB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics. Cancers, 11.","DOI":"10.3390\/cancers11070949"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1634\/theoncologist.2009-0009","article-title":"The role of Src in solid tumors","volume":"14","author":"Wheeler","year":"2009","journal-title":"Oncologist"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family: Roles in cell survival and oncogenesis","volume":"22","author":"Cory","year":"2003","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/0008-5472.CAN-12-1365","article-title":"Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism","volume":"73","author":"Rahmani","year":"2013","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.semcancer.2004.04.002","article-title":"The inhibitor of apoptosis protein family (IAPs): An emerging therapeutic target in cancer","volume":"14","author":"Nachmias","year":"2004","journal-title":"Semin. Cancer Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1034\/j.1600-0609.2002.01549.x","article-title":"Expression of the bcl-2 family of pro- and anti-apoptotic genes in multiple myeloma and normal plasma cells: Regulation during interleukin-6(IL-6)-induced growth and survival","volume":"69","author":"Spets","year":"2002","journal-title":"Eur. J. Haematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1084\/jem.182.5.1545","article-title":"Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Abl","volume":"82","author":"Martin","year":"1995","journal-title":"J. Exp. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.biochem.68.1.383","article-title":"Mammalian caspases: Structure, activation, substrates, and functions during apoptosis","volume":"68","author":"Earnshaw","year":"1999","journal-title":"Annu. Rev. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathmechdis-051022-014433","article-title":"Control of Cell Death in Health and Disease","volume":"19","author":"Kayagaki","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/febs.13554","article-title":"Inhibitor of apoptosis proteins as intracellular signaling intermediates","volume":"283","author":"Kocab","year":"2016","journal-title":"FEBS J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1038\/cdd.2012.59","article-title":"cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation","volume":"19","author":"McComb","year":"2012","journal-title":"Cell Death Differ."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2016.02.040","article-title":"Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells","volume":"375","author":"Gerges","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"68208","DOI":"10.18632\/oncotarget.19919","article-title":"Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells","volume":"8","author":"Feldmann","year":"2017","journal-title":"Oncotarget"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1111\/j.1432-1033.2004.04385.x","article-title":"Modulation of cyclin D1 and early growth response factor-1 gene expression in interleukin-1beta-treated rat smooth muscle cells by n-6 and n-3 polyunsaturated fatty acids","volume":"271","author":"Bousserouel","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00262-011-1078-3","article-title":"Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer","volume":"61","author":"Ming","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CAD.0b013e32834c8683","article-title":"Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma","volume":"23","author":"Baumann","year":"2012","journal-title":"Anticancer Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bcp.2004.04.026","article-title":"Nuclear factor-kappaB: A friend or a foe in cancer?","volume":"68","author":"Shishodia","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","article-title":"SPP1+ macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2","volume":"43","author":"Liu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s11033-019-05212-9","article-title":"Silencing of nuclear factor kappa b 1 gene expression inhibits colony formation, cell migration and invasion via the downregulation of interleukin 1 beta and matrix metallopeptidase 9 in renal cell carcinoma","volume":"47","author":"Teixeira","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","article-title":"Phosphorylation of NF-kappa B and Ikappa B proteins: Implications in cancer and inflammation","volume":"30","author":"Viatour","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: Players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/41\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T05:14:55Z","timestamp":1766726095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/1\/41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["biomedicines14010041"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14010041","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]}}}